{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:50:03Z","timestamp":1648763403195},"reference-count":8,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.leukres.2011.07.005","type":"journal-article","created":{"date-parts":[[2011,7,27]],"date-time":"2011-07-27T22:03:41Z","timestamp":1311804221000},"page":"1658-1659","source":"Crossref","is-referenced-by-count":0,"title":["Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation"],"prefix":"10.1016","volume":"35","author":[{"given":"Jun","family":"Nakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruri","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.07.005_bib0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bbmt.2008.05.020","article-title":"Unrelated umbilical cord blood transplantation using a TBI\/FLAG conditioning regimen for adults with hematologic malignancies","volume":"14","author":"Okada","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2011.07.005_bib0010","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1080\/1042819021000040206","article-title":"Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR","volume":"43","author":"Osumi","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2011.07.005_bib0015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1182\/blood.V100.2.397","article-title":"Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose","volume":"100","author":"Guglielmi","year":"2002","journal-title":"Blood"},{"issue":"Suppl. 3","key":"10.1016\/j.leukres.2011.07.005_bib0020","first-page":"S7","article-title":"Allogeneic bone marrow transplantation for chronic myeloid leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"17","author":"Gratwohl","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2011.07.005_bib0025","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood.V99.10.3861","article-title":"Imatinib mesylate (STI571) in the treatment of relapse of chronic myeloid leukemia after allogeneic stem cell transplantation","volume":"99","author":"Olavarria","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.005_bib0030","first-page":"ECR29","article-title":"Durable molecular response to imatinib mesylate following nonmyeloablative allogeneic stem-cell transplantation for persisting myeloid blast crisis in chronic myeloid leukemia","volume":"88","author":"Staber","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.07.005_bib0035","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1182\/blood-2006-09-046888","article-title":"Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis","volume":"109","author":"Cortes","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.07.005_bib0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/bmt.2009.136","article-title":"Dasatinib may not suppress the GVL effect of donor lymphocyte infusions for CML","volume":"45","author":"Garland","year":"2010","journal-title":"Bone Marrow Transplant"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T23:27:25Z","timestamp":1543620445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611003341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0145212611003341"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.07.005","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}